Oral bisphosphonate adverse effects in 849 patients with metabolic bone diseases.

Hormones (Athens, Greece)

Volumn 6, Issue 3, 2007, Pages 233-241

  Anastasilakis, Athanasios D ^a   Goulis, Dimitrios G ^a   Kita, Marina ^a   Avramidis, Avraam ^a  

^a Aristotle University of Thessaloniki   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; DRUG DERIVATIVE; ETIDRONIC ACID; RISEDRONIC ACID;

AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; GASTROINTESTINAL DISEASE; HUMAN; MIDDLE AGED; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE OSTEOPOROSIS; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; ALENDRONATE; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; ETIDRONIC ACID; GASTROINTESTINAL DISEASES; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; TREATMENT OUTCOME;

EID: 35748956749     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)